Location: New York, NY
CIK: 0001974915 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 17, 2026
Total Value: $2.941B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ABVX | Abivax SA | 1,900,000 | $256M | 8.7% | $108.56 | — | SPONSORED ADS | 00370M103 |
| QQQ | Invesco QQQ Trust Series 1 | 350,000 | $215M | 7.3% | — | — | Put | 46090E103 |
| ACLX | Arcellx Inc | 2,925,000 | $191M | 6.5% | $73.32 | +8.8% | COMMON STOCK | 03940C100 |
| TERN | Terns Pharmaceuticals Inc | 4,500,000 | $182M | 6.2% | $23.11 | 0.0% | COM | 880881107 |
| BMRN | BioMarin Pharmaceutical Inc | 3,000,000 | $178M | 6.1% | $55.48 | -1.9% | COM | 09061G101 |
| GMED | Globus Medical Inc | 1,275,000 | $111M | 3.8% | $62.94 | +20.6% | CL A | 379577208 |
| NRIX | Nurix Therapeutics Inc | 4,690,000 | $88.97M | 3.0% | $12.99 | +10.6% | COM | 67080M103 |
| ALC | Alcon AG | 1,105,000 | $87.09M | 3.0% | $86.36 | -10.8% | ORD SHS | H01301128 |
| DXCM | Dexcom Inc | 1,275,000 | $84.62M | 2.9% | $72.03 | -10.3% | COM | 252131107 |
| MRK | Merck & Co Inc | 775,000 | $81.58M | 2.8% | $93.24 | 0.0% | COM | 58933Y105 |
| TSHA | Taysha Gene Therapies Inc | 13,750,000 | $75.63M | 2.6% | $3.90 | +24.4% | COM SHS | 877619106 |
| ABT | Abbott Laboratories | 600,000 | $75.17M | 2.6% | $128.68 | -1.1% | COM | 002824100 |
| IMTX | Immatics NV | 6,125,000 | $64.31M | 2.2% | $9.24 | +9.2% | SHS | N44445109 |
| TYRA | Tyra Biosciences Inc | 2,425,000 | $63.75M | 2.2% | $14.73 | +24.7% | COM | 90240B106 |
| BCAX | Bicara Therapeutics Inc | 3,575,000 | $60.17M | 2.0% | $14.08 | +21.3% | COM | 055477103 |
| ARWR | Arrowhead Pharmaceuticals Inc | 900,000 | $59.75M | 2.0% | $49.01 | 0.0% | COM | 04280A100 |
| ELVN | Enliven Therapeutics Inc | 3,830,000 | $58.98M | 2.0% | $19.91 | +0.0% | COM | 29337E102 |
| IRON | Disc Medicine Inc | 735,000 | $58.37M | 2.0% | $65.10 | +29.8% | COM | 254604101 |
| JAZZ | Jazz Pharmaceuticals PLC | 290,000 | $49.3M | 1.7% | $108.63 | +41.1% | SHS USD | G50871105 |
| DAWN | Day One Biopharmaceuticals Inc | 5,200,000 | $48.46M | 1.6% | $10.24 | -18.4% | COM | 23954D109 |
| LXEO | Lexeo Therapeutics Inc | 4,475,000 | $44.44M | 1.5% | $7.30 | +25.0% | COM | 52886X107 |
| ANRO | Alto Neuroscience Inc | 2,485,000 | $44.23M | 1.5% | $12.14 | +3.7% | COM SHS | 02157Q109 |
| APGE | Apogee Therapeutics Inc | 550,000 | $41.51M | 1.4% | $43.82 | +43.7% | COM | 03770N101 |
| OLMA | Olema Pharmaceuticals Inc | 1,650,000 | $41.25M | 1.4% | $17.79 | 0.0% | COM | 68062P106 |
| AXSM | Axsome Therapeutics Inc | 210,000 | $38.35M | 1.3% | $120.35 | +16.0% | COM | 05464T104 |
| ASND | Ascendis Pharma A/S | 175,000 | $37.32M | 1.3% | $180.30 | — | SPONSORED ADR | 04351P101 |
| RAPP | Rapport Therapeutics Inc | 1,110,000 | $33.68M | 1.1% | $19.26 | +43.7% | COM | 75383L102 |
| SLDB | Solid Biosciences Inc | 5,815,000 | $32.8M | 1.1% | $6.44 | -15.8% | COM NEW | 83422E204 |
| CLDX | Celldex Therapeutics Inc | 1,165,000 | $31.64M | 1.1% | $20.34 | +29.5% | COM NEW | 15117B202 |
| SRRK | Scholar Rock Holding Corp | 700,000 | $30.84M | 1.0% | $37.53 | -0.1% | COM | 80706P103 |
| KALV | KalVista Pharmaceuticals Inc | 1,890,000 | $30.52M | 1.0% | $12.75 | +3.8% | COM | 483497103 |
| VERA | Vera Therapeutics Inc | 550,000 | $27.85M | 0.9% | $34.48 | +3.0% | CL A | 92337R101 |
| XENE | Xenon Pharmaceuticals Inc | 600,000 | $26.89M | 0.9% | $37.23 | +12.8% | COM | 98420N105 |
| LNTH | Lantheus Holdings Inc | 360,000 | $23.96M | 0.8% | $63.74 | -8.7% | COM | 516544103 |
| RVMD | Revolution Medicines Inc | 295,000 | $23.5M | 0.8% | $38.42 | +70.7% | COM | 76155X100 |
| ZYME | Zymeworks Inc | 865,000 | $22.78M | 0.8% | $12.80 | +70.4% | COM | 98985Y108 |
| IMCR | Immunocore Holdings PLC | 585,000 | $20.31M | 0.7% | $34.71 | — | ADS | 45258D105 |
| UPB | Upstream Bio Inc | 720,000 | $19.55M | 0.7% | $24.89 | 0.0% | COM | 91678A107 |
| BBNX | Beta Bionics Inc | 600,000 | $18.28M | 0.6% | $14.44 | +84.9% | COM | 08659B102 |
| CBIO | Crescent Biopharma Inc | 1,500,000 | $17.79M | 0.6% | $12.74 | 0.0% | COM | G2545C104 |
| BCRX | BioCryst Pharmaceuticals Inc | 2,250,000 | $17.55M | 0.6% | $7.23 | 0.0% | COM | 09058V103 |
| PEN | Penumbra Inc | 50,000 | $15.55M | 0.5% | $276.19 | 0.0% | COM | 70975L107 |
| GERN | Geron Corp | 11,320,000 | $14.94M | 0.5% | $3.11 | -59.6% | COM | 374163103 |
| RGEN | Repligen Corp | 83,000 | $13.6M | 0.5% | $121.47 | +28.9% | COM | 759916109 |
| ZBH | Zimmer Biomet Holdings Inc | 150,000 | $13.49M | 0.5% | $94.58 | 0.0% | COM | 98956P102 |
| BMY | Bristol-Myers Squibb Co | 250,000 | $13.48M | 0.5% | $47.53 | 0.0% | COM | 110122108 |
| GLUE | Monte Rosa Therapeutics Inc | 775,000 | $12.15M | 0.4% | $5.30 | +154.4% | COM | 61225M102 |
| FULC | Fulcrum Therapeutics Inc | 950,000 | $10.74M | 0.4% | $10.18 | 0.0% | COM | 359616109 |
| SVRA | Savara Inc | 1,606,000 | $9.684M | 0.3% | $4.17 | +17.3% | COM | 805111101 |
| ENGN | Engene Holdings Inc | 1,055,000 | $9.527M | 0.3% | $7.93 | +1.1% | COM | 29286M105 |
| AGIO | Agios Pharmaceuticals Inc | 325,000 | $8.847M | 0.3% | $36.07 | -2.7% | COM | 00847X104 |
| — | Definium Therapeutics Inc | 637,000 | $8.529M | 0.3% | $13.39 | — | COM NEW | 60255C885 |
| DNLI | Denali Therapeutics Inc | 465,000 | $7.677M | 0.3% | $16.88 | 0.0% | COM | 24823R105 |
| MYGN | Myriad Genetics Inc | 1,223,000 | $7.521M | 0.3% | $6.61 | +9.8% | COM | 62855J104 |
| TECX | Tectonic Therapeutic Inc | 328,000 | $6.842M | 0.2% | $18.58 | 0.0% | COM | 878972108 |
| NVCR | Novocure Ltd | 525,000 | $6.788M | 0.2% | $13.24 | -3.0% | ORD SHS | G6674U108 |
| MPLT | MapLight Therapeutics Inc | 385,000 | $6.763M | 0.2% | $16.75 | 0.0% | COM | 56565P103 |
| GILD | Gilead Sciences Inc | 50,000 | $6.137M | 0.2% | $120.88 | 0.0% | COM | 375558103 |
| VYGR | Voyager Therapeutics Inc | 1,475,000 | $5.797M | 0.2% | $6.46 | — | COM | 92915B106 |
| DBVT | DBV Technologies SA | 300,000 | $5.751M | 0.2% | $19.17 | — | SPONSORED ADS | 23306J309 |
| MIRM | Mirum Pharmaceuticals Inc | 66,000 | $5.213M | 0.2% | $71.78 | 0.0% | COM | 604749101 |
| NYXH | Nyxoah SA | 1,107,000 | $5.092M | 0.2% | $8.73 | -41.1% | SHS | B6S7WD106 |
| NUVL | Nuvalent Inc | 46,000 | $4.627M | 0.2% | $86.50 | +14.0% | COM | 670703107 |
| LENZ | LENZ Therapeutics Inc | 275,000 | $4.4M | 0.1% | $29.15 | 0.0% | COM | 52635N103 |
| RZLT | Rezolute Inc | 1,686,000 | $3.979M | 0.1% | $7.84 | 0.0% | COM NEW | 76200L309 |
| PASG | Passage Bio Inc | 305,000 | $3.599M | 0.1% | $6.96 | +24.0% | COM NEW | 702712209 |
| STRO | Sutro Biopharma Inc | 243,000 | $2.812M | 0.1% | $9.49 | 0.0% | COM SHS | 869367201 |
| GPCR | Structure Therapeutics Inc | 35,000 | $2.434M | 0.1% | $69.55 | — | SPONSORED ADS | 86366E106 |
| DYN | Dyne Therapeutics Inc | 120,000 | $2.347M | 0.1% | $12.17 | +55.7% | COM | 26818M108 |
| BDTX | Black Diamond Therapeutics Inc | 870,000 | $2.114M | 0.1% | $5.15 | -31.2% | COM | 09203E105 |
| OKUR | OnKure Therapeutics Inc | 635,000 | $1.841M | 0.1% | $15.14 | -80.2% | COM CL A | 68277Q105 |
| FATE | Fate Therapeutics Inc | 1,725,000 | $1.695M | 0.1% | $3.20 | -62.5% | COM | 31189P102 |
| ALEC | Alector Inc | 755,000 | $1.178M | 0.0% | $1.45 | +22.7% | COM | 014442107 |
| TENX | Tenax Therapeutics Inc | 53,439 | $651K | 0.0% | $3.62 | +140.2% | COM NEW | 88032L605 |
| RGNX | REGENXBIO Inc | 34,000 | $490K | 0.0% | $12.46 | 0.0% | COM | 75901B107 |
| MGNX | MacroGenics Inc | 280,000 | $451K | 0.0% | $14.22 | -88.9% | COM | 556099109 |